Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Brenner

Showing results (111-120 of 126) with videos related to

Pageof 13
Sort By:
Acta Neuropathologica Communications|June 26, 2026
A rare missense variant impacting NEK1 kinase function is associated with ALSDavid Brenner, Anna Ponomarenko, Iris Petrut, et al.
Brain Communications|May 24, 2023
Spectrum and frequency of genetic variants in sporadic amyotrophic lateral sclerosisWolfgang P Ruf, Matej Boros, Axel Freischmidt, et al.
Annals of Neurology|August 9, 2025
Targeted Proteomics upon Treatment with Tofersen Identifies Novel Response Markers for Superoxide Dismutase 1-Linked Amyotrophic Lateral SclerosisChristina Steffke, Karthik Baskar, Franziska Bachhuber, et al.
Medrxiv : the Preprint Server for Health Sciences|May 19, 2025
Single cell multiomics reveals drivers of metabolic dysfunction-associated steatohepatitisWeston Elison, Lei Chang, Yang Xie, et al.
Brain : a Journal of Neurology|October 16, 2019
Reply: Adult-onset distal spinal muscular atrophy: a new phenotype associated with KIF5A mutationsDavid Brenner, Angela Rosenbohm, Rüstem Yilmaz, et al.
Brain : a Journal of Neurology|January 18, 2018
Hot-spot KIF5A mutations cause familial ALSDavid Brenner, Rüstem Yilmaz, Kathrin Müller, et al.
Life Sciences in Space Research|November 6, 2022
Looking on the horizon; potential and unique approaches to developing radiation countermeasures for deep space travelRihana S Bokhari, Afshin Beheshti, Sarah E Blutt, et al.
Eclinicalmedicine|February 22, 2024
Effects of tofersen treatment in patients with <i>SOD1</i>-ALS in a "real-world" setting - a 12-month multicenter cohort study from the German early access programMaximilian Wiesenfarth, Johannes Dorst, David Brenner, et al.
Neurobiology of Aging|October 22, 2018
Association of NIPA1 repeat expansions with amyotrophic lateral sclerosis in a large international cohortGijs H P Tazelaar, Annelot M Dekker, Joke J F A van Vugt, et al.
Neurology|February 23, 2026
Incidence and Survival Rates of Frontotemporal Lobar Degeneration: Population-Based Registry StudyGabriele Nagel, Raphael Simon Peter, Zeljko Uzelac, et al.
Pageof 13

Showing results (111-120 of 126) with videos related to

Sort By:
Pageof 13
Acta Neuropathologica Communications|June 26, 2026
A rare missense variant impacting NEK1 kinase function is associated with ALSDavid Brenner, Anna Ponomarenko, Iris Petrut, et al.
Brain Communications|May 24, 2023
Spectrum and frequency of genetic variants in sporadic amyotrophic lateral sclerosisWolfgang P Ruf, Matej Boros, Axel Freischmidt, et al.
Annals of Neurology|August 9, 2025
Targeted Proteomics upon Treatment with Tofersen Identifies Novel Response Markers for Superoxide Dismutase 1-Linked Amyotrophic Lateral SclerosisChristina Steffke, Karthik Baskar, Franziska Bachhuber, et al.
Medrxiv : the Preprint Server for Health Sciences|May 19, 2025
Single cell multiomics reveals drivers of metabolic dysfunction-associated steatohepatitisWeston Elison, Lei Chang, Yang Xie, et al.
Brain : a Journal of Neurology|October 16, 2019
Reply: Adult-onset distal spinal muscular atrophy: a new phenotype associated with KIF5A mutationsDavid Brenner, Angela Rosenbohm, Rüstem Yilmaz, et al.
Brain : a Journal of Neurology|January 18, 2018
Hot-spot KIF5A mutations cause familial ALSDavid Brenner, Rüstem Yilmaz, Kathrin Müller, et al.
Life Sciences in Space Research|November 6, 2022
Looking on the horizon; potential and unique approaches to developing radiation countermeasures for deep space travelRihana S Bokhari, Afshin Beheshti, Sarah E Blutt, et al.
Eclinicalmedicine|February 22, 2024
Effects of tofersen treatment in patients with <i>SOD1</i>-ALS in a "real-world" setting - a 12-month multicenter cohort study from the German early access programMaximilian Wiesenfarth, Johannes Dorst, David Brenner, et al.
Neurobiology of Aging|October 22, 2018
Association of NIPA1 repeat expansions with amyotrophic lateral sclerosis in a large international cohortGijs H P Tazelaar, Annelot M Dekker, Joke J F A van Vugt, et al.
Neurology|February 23, 2026
Incidence and Survival Rates of Frontotemporal Lobar Degeneration: Population-Based Registry StudyGabriele Nagel, Raphael Simon Peter, Zeljko Uzelac, et al.
Pageof 13